• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    Director Bakhshi Nandita converted options into 602 shares and was granted 551 shares, increasing direct ownership by 416% to 1,430 units (SEC Form 4)

    6/3/25 4:27:27 PM ET
    $KWR
    Major Chemicals
    Industrials
    Get the next $KWR alert in real time by email
    SEC FORM 4 SEC Form 4
    FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
    Washington, D.C. 20549

    STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

    Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
    or Section 30(h) of the Investment Company Act of 1940
    OMB APPROVAL
    OMB Number: 3235-0287
    Estimated average burden
    hours per response: 0.5
      
    Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
      
    Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
    1. Name and Address of Reporting Person*
    BAKHSHI NANDITA

    (Last) (First) (Middle)
    901 E. HECTOR STREET

    (Street)
    CONSHOHOCKEN PA 19428-2380

    (City) (State) (Zip)
    2. Issuer Name and Ticker or Trading Symbol
    QUAKER CHEMICAL CORP [ KWR ]
    5. Relationship of Reporting Person(s) to Issuer
    (Check all applicable)
    X Director 10% Owner
    Officer (give title below) Other (specify below)
    3. Date of Earliest Transaction (Month/Day/Year)
    05/31/2025
    4. If Amendment, Date of Original Filed (Month/Day/Year)
    6. Individual or Joint/Group Filing (Check Applicable Line)
    X Form filed by One Reporting Person
    Form filed by More than One Reporting Person
    Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
    1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V Amount (A) or (D) Price
    Common Stock 05/31/2025 M 596 A (1) 873 D
    Common Stock 05/31/2025 M 6 A (2) 879 D
    Common Stock 06/01/2025 A 551(3) A $108.84 1,430 D
    Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
    (e.g., puts, calls, warrants, options, convertible securities)
    1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
    Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
    Restricted Stock Units (1) 05/31/2025 M 596 (4) (4) Common Stock 596 $0 0 D
    Dividend Equivalent Rights (2) 05/31/2025 M 6 (2) 05/31/2025 Common Stock 6 (2) 0 D
    Restricted Stock Units (5) 06/01/2025 A 1,198(6) (6) (6) Common Stock 1,198 $0 1,198 D
    Explanation of Responses:
    1. Restricted stock units convert into common stock on a one-for-one basis.
    2. Settlement of dividend equivalent rights in connection with vesting of restricted stock unit. The rights accrued when and as dividends were paid on KWR common stock. Each dividend equivalent right was the economic equivalent of one share of KWR common stock.
    3. Reflects 75% of the Director's annual retainer paid in shares pursuant to the terms of the 2023 Director Stock Ownership Plan.
    4. On July 31, 2024, the reporting person was granted time-based restricted stock units that vested 100% on May 31, 2025.
    5. Time-based restricted stock units granted under the Company's Long-Term Performance Incentive Plan to Quaker Houghton's non-executive directors as part of their 2025 compensation. Each restricted stock unit represents a contingent right to receive one share of KWR common stock.
    6. The restricted stock units vest 100% on May 31, 2026. Dividend equivalent rights accrue with respect to these restricted stock units when and as dividends are paid on KWR's common stock.
    Remarks:
    Victoria K. Gehris, Attorney-in-Fact for Nandita Bakhshi 06/03/2025
    ** Signature of Reporting Person Date
    Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
    * If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
    ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
    Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
    Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
    Get the next $KWR alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $KWR

    DatePrice TargetRatingAnalyst
    6/9/2025$146.00Hold → Buy
    Jefferies
    1/7/2025$200.00 → $170.00Overweight → Neutral
    Piper Sandler
    5/16/2024$220.00Overweight
    Piper Sandler
    6/2/2023$250.00Buy
    Stifel
    10/25/2022$196.00Outperform
    RBC Capital Mkts
    1/18/2022$265.00Neutral → Buy
    Seaport Research Partners
    More analyst ratings